IL1B and type 2 diabetes mellitus: A hallmark of T2DM is the occurrence of IAPP-derived amyloid aggregates in the pancreatic islets, which is associated with β-cell toxicity and inflammasome-mediated IL-1β production and inflammation [34], leading to the characteristic loss of β-cell mass in type 2 diabetes mellitus [4].